Clinical trial Recruiting at 3 sites Interventional Ages 75 and up

Rehabilitation to prevent nearby spine degeneration after lumbar fusion in high-risk older adults

Official title: A Randomized Controlled Trial of Multimodal Rehabilitation Versus Standard Care on Adjacent Segment Degeneration in Frail Elderly Patients Undergoing Short-Segment Lumbar Fusion

Run by Xuanwu Hospital, Beijing · NCT07396051 · Data updated 2026-11-12

We will see if a structured multimodal rehab program started 12 weeks after short-segment lumbar fusion helps delay or reduce adjacent segment degeneration in frail people aged 75 and older.

More Adjacent Segment Degeneration trials

Quick facts

Study typeInterventional
Ages75 Years and up
SexAll
Enrollment212 (estimated)
SponsorXuanwu Hospital, Beijing
Academic / other
Locations3 sites (Beijing, Beijing Municipality and 2 other locations)
StatusRecruiting
StartedJanuary 25, 2026
Main results expectedMarch 1, 2028
Study endsMarch 1, 2028
Registry record updatedFebruary 17, 2026
Trial IDNCT07396051 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are frail adults aged 75 or older scheduled for first-time posterior short-segment (1–2 level) lumbar instrumented fusion who can give informed consent and commit to supervised rehab and two years of follow-up.

Probably not a fit

Patients with prior lumbar surgery, lumbar disease from tumor/trauma/infection/congenital deformity, or severe comorbidities (for example advanced dementia or severe cardiopulmonary disease) that prevent participation are unlikely to benefit from this rehabilitation program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized controlled trial enrolling frail patients aged 75 and older undergoing first-time posterior short-segment (1–2 level) lumbar instrumented fusion. Participants are randomized to a supervised multimodal rehabilitation program begun 12 weeks after surgery or to standard postoperative care, with interventions targeting paraspinal muscle endurance, global alignment, bone health, and overall frailty. The rehab program combines progressive resistance and stabilization training, bone-loading and balance exercises, and optimization of nutrition/osteoporosis management under physiotherapist supervision. Outcomes focus on imaging and clinical measures of adjacent segment degeneration and functional status over a two-year follow-up.

Why it matters

Potential benefit: If successful, the program could slow degeneration at levels next to the fusion, reduce pain and disability, and lower the likelihood of needing additional spine surgery.

How similar studies have gone: While components like resistance training and bone-loading exercises have shown benefit for muscle strength and bone density in older adults, a targeted multimodal program specifically designed to prevent adjacent segment degeneration after fusion is novel and not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 75 years.
* Classified as "frail" according to the Fried frailty phenotype.
* Scheduled for first-time, posterior short-segment (1-2 levels) lumbar instrumented fusion surgery.
* Willing and able to provide written informed consent and complete the 2-year follow-up.

Exclusion Criteria:

* History of previous lumbar spine surgery.
* Lumbar pathology due to tumor, trauma, infection, or congenital deformity.
* Comorbidities with a severe impact on prognosis or ability to participate in rehabilitation (e.g., severe cardiopulmonary disease, advanced dementia).

Where it's running

  • Beijing Friendship Hospital
    Beijing, Beijing Municipality, China
    Recruiting
  • Peking University First Hospital, Beijing, Beijing 10034
    Beijing, Beijing Municipality, China
    Recruiting
  • Xuanwu Hospital, Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.